The analysis of 2,3-dicarboxypropane-1,1-diphosphonic acid-coated magnetite nanoparticles under an external magnetic field and their radiolabeling for possible theranostic applications by Perić, Marko et al.
This is an Accepted Manuscript, which has been through the  
Royal Society of Chemistry peer review process and has been 
accepted for publication.
Accepted Manuscripts are published online shortly after 
acceptance, before technical editing, formatting and proof reading. 
Using this free service, authors can make their results available 
to the community, in citable form, before we publish the edited 
article. We will replace this Accepted Manuscript with the edited 
and formatted Advance Article as soon as it is available.
You can find more information about Accepted Manuscripts in the 
author guidelines.
Please note that technical editing may introduce minor changes 
to the text and/or graphics, which may alter content. The journal’s 
standard Terms & Conditions and the ethical guidelines, outlined 
in our author and reviewer resource centre, still apply. In no 
event shall the Royal Society of Chemistry be held responsible 
for any errors or omissions in this Accepted Manuscript or any 
consequences arising from the use of any information it contains. 
Accepted Manuscript
rsc.li/njc
NJC
New Journal of Chemistry  A journal for new directions in chemistry
www.rsc.org/njc
ISSN 1144-0546
PAPER
Jason B. Benedict et al.
The role of atropisomers on the photo-reactivity and fatigue of 
diarylethene-based metal–organic frameworks
Volume 40 Number 1 January 2016 Pages 1–846
NJC
New Journal of Chemistry  A journal for new directions in chemistry
View Article Online
View Journal
This article can be cited before page numbers have been issued, to do this please use:  M. Peric, M.
Radovi, M. D. Mirkovi, A. S. Nikolic, P. Iskrenovi, D. Jankovic and S. Vranješ Djuri, New J. Chem., 2019,
DOI: 10.1039/C8NJ06478D.
Journal Name
ARTICLE
This journal is © The Royal Society of Chemistry 20xx J. Name., 2013, 00, 1-3 | 1
Please do not adjust margins
Please do not adjust margins
a.Vinča Institute of Nuclear Sciences, University of Belgrade, P. O. BOX 522, 
Belgrade, Serbia
b.Faculty of Chemistry, University of Belgrade, Studentski Trg 12–16, 11001 
Belgrade, Serbia
c. Faculty of Physics, University of Belgrade, Studentski Trg 12, 11001 Belgrade, 
Serbia
d.† Corresponding author E-mail: markop@chem.bg.ac.rs.
Received 00th January 20xx,
Accepted 00th January 20xx
DOI: 10.1039/x0xx00000x
www.rsc.org/
The analysis of the 2,3-dicarboxypropane-1,1-diphosphonic acid 
coated magnetite nanoparticles in the external magnetic field and 
their radiolabeling for possible theranostic application 
Marko Perić*a, Magdalena Radovića, Marija Mirkovića, Aleksandar S. Nikolićb, Predrag Iskrenovićc, 
Drina Jankovića and Sanja Vranješ-Đurića
The advances in nanotechnology are directed toward development of new theranostic  agents based on magnetic 
nanoparticles that can be used for both cancer detecting and treating.  In this study, 2,3-dicarboxypropane-1,1-
diphosphonic acid coated magnetite nanoparticles (Fe3O4-DPD MNPs) were evaluated for the theranostic application by 
using different methods. The magnetic hyperthermia efficiency of Fe3O4-DPD MNPs was investigated in saline solution 
with ionic strenghts  between 0.05-1.0 mol/dm3. For better understanding of hyperthermia, the behavior of Fe3O4-DPD 
MNPs in the non-alternating magnetic field was followed by measuring the transparency of the sample. Furthermore, the 
radiotracer method using radionuclides 99mTc and 90Y was applied as a reliable and powerful method for evaluating the in 
vivo behavior of a nanoprobe. High radiolabeling yield (>93 %), in vitro and in vivo stability of radiolabeled nanoparticles 
and high heating effect, paving the way for the possible theranostic application of Fe3O4-DPD MNPs.
1 Introduction
The rapid development of nanotechnology enabled 
biomedical application of large number of newly emerged 
nanomaterials. Magnetic nanoparticles (MNPs) offer several 
opportunities in the application including the magnetic 
resonance imaging (MRI), hyperthermia treatment of 
malignant tissues, site-specific drug/radionuclide delivery and 
therefore they represent powerful theranostic agent.1
During magnetic hyperthermia treatment, MNPs are 
exposed to an alternating magnetic field (MF), generating the 
heat due to the magnetic hysteresis loss mechanism and 
Brownian and Neel relaxation phenomena.2,3 Temperature 
between 42-46 oC induce changes in the protein metabolism 
that may finally result in cellular degradation and apoptosis of 
the cancer cells while causing minimal damage to the 
surrounding healthy cells.4 Hyperthermia treatment is usually 
used in combination with other cancer therapy options such as 
radiotherapy or chemotherapy because the simultaneous 
delivery of heat and radionuclides/drugs is much more 
effective in achieving therapeutic effects.5 Furthermore, 
multifunctional radiolabeled MNPs nanoparticles with the 
capability of detecting and destroying of cancer cells with the 
potential for the visualization of therapy have been considered 
as the best choice for the application in  cancer therapy.6 
Radiolabeling of MNPs with gamma or positron emitters allows 
combined hyperthermia treatment and MRI/PET or MRI/SPECT 
imaging.7,8 In contrast, labeling with beta emitters provides an 
opportunity for MRI diagnostic and dual hyperthermia-
radionuclide therapy.
The biomedical applications of MNPs depend on their 
colloidal and chemical stability and aggregation levels in 
physiological conditions. The ionic and protein composition of 
biological media has strong influence on the physicochemical 
and biological behavior of MNPs.9,10 To improve 
biocompatibility and colloidal stability of MNPs in biological 
systems appropriate surface coatings is necessary.11 To the 
best of our knowledge, there is a small number of studies 
using bisphosphonates (BPs) as coatings in spite of their great 
affinity towards metal ions and biocompatibility.12,13 
Bisphosphonates are well-known drugs in osteoporosis and 
oncology due to the high binding affinity to the surface of the 
metabolically active bone. The 2,3-dicarboxypropane-1,1-
diphosphonic acid (DPD) is water soluble and biocompatible 
bisphosphonate which provide suitable dispersion stability and 
reduces the cytotoxicity of the naked Fe3O4 MNPs.6,7 In 
addition, DPD as a tetradentate ligand, serves as an effective 
chelator. Complex DPD with 99mTc has been widely accepted 
for bone scintigraphy because of its high sensitivity and easy 
evaluation of the whole skeletal system.14 Also, DPD is capable 
to form stable complexes with 90Y.15 Conjugation of DPD to the 
surface of iron oxide MNPs and their labeling with 68Ga, make 
them suitable for PET/MRI imaging.7
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In this study, the interaction of Fe3O4-DPD MNPs (Fig. 1) 
with external magnetic field (MF) gradient was analyzed to test 
their potential for the possible application in hyperthermia 
treatment. The heating efficiency of MNPs in biological 
conditions remains poorly understood, especially regarding the 
influence of their dispersion state. Hence, the behavior of 
Fe3O4-DPD MNPs in non-alternating external MF, by constant 
measuring of laser beam transparency through ferrofluid 
sample was monitored. These measurements were carried out 
before switching on MF, when the field was applied and after 
the switching off MF. Using the transparency analysis of 
ferrofluid in non-alternating external MF and changing the 
ionic strengths of the sample, the combined effects of MF and 
electrolyte were monitored. This allows better comprehension 
of the behavior of Fe3O4-DPD MNPs in external MF, in the 
absence and the presence of an electrolyte, and consequently 
the more comprehensive understanding of hyperthermia. 
Furthermore, we described the advances of DPD coatings for 
the radiolabeling of MNPs with 99mTc for their potential 
application as agent for SPECT diagnostics and hyperthermia 
therapy as well as with 90Y for dual hyperthermia-radionuclide 
based therapy.
2 Experimental
2,3-Dicarboxypropane-1,1-diphosphonic acid (DPD) was 
synthesized in the Laboratory for Radioisotopes of the Vinča 
Institute of Nuclear Sciences,16 while other materials and 
reagents for the preparation of Fe3O4-DPD MNPs were 
purchased from commercial sources without further 
purification.
Synthesis and detailed physicochemical properties of 
Fe3O4-DPD MNPs were previously described.7 Briefly, after 
synthesis of Fe3O4 MNPs by coprecipitation method, DPD 
water solution (Fe3O4:DPD=1:1) was added and the coating 
reaction was carried out overnight at room temperature. The 
excess of unreacted DPD was removed by dialysis against 
deionized water for one day.
99mTc (t1/2 =6 h, Eγ = 140 keV) was freshly eluted from a 
99Mo/99mTc generator (Vinča Institute of Nuclear Sciences, 
Belgrade, Serbia).
90YCl3 was purchased from Polatom, Poland, in a no-carrier-
added form (29.64 GBq/cm3, in 0.05 mol/dm3 HCl,18.5 TBq/mg 
Y, according to the product specification).
2.1 MNPs characterization
The mean particle diameters were determined in the 
suspension of 20 µl of Fe3O4-DPD MNPs in 3 ml saline solution 
with ionic strengths between 0.05-1.0 mol/dm3 by using Zeta–
sizer Nano ZS with a 633 nm He–Ne laser (Malvern 
Instruments Inc, UK). Results are expressed as the Z average, 
representing an average hydrodynamic particle diameter. The 
measurements were performed at room temperature.
2.2 Measurements in alternating and non-alternating MF
The magnetic hyperthermia efficiency of Fe3O4-DPD MNPs 
was tested by using Commercial AC applicator (model DM100 
by nB nanoscale Biomagnetics). The heat generation of the 
dispersions Fe3O4-DPD MNPs under alternating magnetic field 
(30 mT) and the resonant frequencies between 252–577 kHz 
was measured directly on the samples dispersed in water. The 
heating efficiency of MNPs (2 mg/ml) is defined as specific 
power absorption (SPA) and is calculated according to the 
following formula: SPA = (Cp·mw/mm)·(∆T/∆t), where Cp is the 
specific heat capacity of the medium (Cp ~ Cwater = 4.18 J g-1 K-
1), mw and mm are the masses of the medium (water) and 
magnetic nanoparticles, while ∆T/∆t is the initial slope of the 
time-dependent temperature curve.17
For the analysis in non-alternating external MF, device 
developed in our laboratory was used.18 Sanyo laser diode 
DL5147-040 in the single mode regime at wavelength                       
λ= 655nm was applied. Transmitted laser light was measured 
with a photodiode.
2.3 Radiolabeling of Fe3O4-DPD MNPs 
2.3.1 99mTc-labeling
Radiolabeling of Fe3O4-DPD MNPs was performed with 
99mTc using SnCl2 as a reducing agent. 100 µl of Na99mTcO4 
(18.5 MBq) and 50 µl of freshly prepared tin(II)-solution (50 mg 
of SnCl2x2H2O in 5 ml of 0.1 mol/dm3 HCl) were added to the 
suspension of 50 µl of Fe3O4-DPD MNPs (5 mg/ml) in 1 ml of 
distilled water. The mixture was immediately adjusted with 0.1 
mol/dm3 HCl to pH 6 and gently stirred at room temperature 
for 30 min. 
Figure 1 - Schematic depiction of Fe3O4-DPD MNPs
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Radiolabeled Fe3O4-DPD MNPs were then separated from 
free 99mTc by precipitation with the help of a permanent 
magnet. The radiolabeling yield of the 99mTc-Fe3O4-DPD MNPs 
was determined as the ratio of the measured radioactivity 
retained in the precipitate after magnetic separation and the 
known radioactivity used for the radiolabeling. The 
radioactivity was measured using a CRC-15 beta dose 
calibrator (Capintec Ramsey, NJ, USA) and gamma counter 
Wizard 2480 (Perkin Elmer, USA). Another method used for 
the measuring of radiolabeling yield was ascending instant 
thin-layer chromatography (ITLC) on silica gel (SG) coated fiber 
sheets. Using acetone as the mobile phase free 99mTcO4− 
migrates to the front of the ITLC strip (Rf = 0.8–1.0) leaving the 
reduced/hydrolyzed 99mTc along with the radiolabeled complex 
(99mTc–MNPs) at the origin. In the mixture of pyridine:acetic 
acid:water (3:5:1.5), 99mTc-hydrolyzate remained at the origin, 
while both free 99mTcO4− and 99mTc–Fe3O4-DPD MNPs migrated 
with the solvent front. The final percentage of the formed 
99mTc–MNPs complex was determined based on the calculation 
of radiochemical purity in both systems.
2.3.2 90Y labeling
90Y labeling of Fe3O4-DPD MNPs was performed using the 
method previously applied for the radiolabeling of phosphate 
coated MNPs.19 Briefly, 90YCl3 solution (6 μl, containing 
approximately 185 MBq) was added to an aqueous suspension 
of 5 mg/ml Fe3O4-DPD MNPs at pH 4-5 and incubated at room 
temperature on a shaker for 1 h. 
Magnetic decantation and ITLC, performed on SG sheets 
with saline as the mobile phase, were used to quantify the 
radiolabelling yield. In this system, 90Y-labeled MNPs remained 
at the origin (Rf = 0.0–0.1), while the unbound 90Y3+ migrated 
with the solvent front (Rf = 0.8–0.9). Since 90Y is a pure β-
emitter it can only be detected by the measured 
‘‘bremsstrahlung’’20,21 in a dose calibrator or gamma counter. 
All measurements were carried out under the same geometric 
conditions.
2.4 In vitro stability testing
The in vitro stability of radiolabeled MNPs (50 µl) was 
tested in different solutions (1 ml): saline (0.9 % NaCl), human 
serum (4% water solution of human serum albumin) and 0.01 
mol/dm3 DTPA solution, after incubation at 37 0C over a period 
of 24 h for 99mTc-Fe3O4-DPD MNPs and over a period of 72 h 
for 90Y-Fe3O4-DPD MNPs. Small amounts of sample were taken 
at different time points and analyzed by ITLC-SG using above 
mentioned mobile phases.
2.5 Biodistribution and in vivo stability studies
Biodistribution studies were carried out in healthy male 4-
week old Wistar rats (100 ± 10 g body weight, Laboratory for 
Biology, Vinča Institute of Nuclear Sciences) according to the 
guidelines of the European Council Directive (86/609/EEC) and 
the Serbian Laboratory Animal Science Association (SLASA). 
Radiolabeled MNPs were intravenously injected through the 
tail vein in a maximum volume of 0.15 ml (0.3 mg Fe3O4-DPD 
MNPs in saline, approx. 2.5 MBq). The animals were sacrificed 
at the following time points (t = 0.5, 1, 2 and 24 h) for 99mTc-
Fe3O4-DPD and (t = 0.5, 1, 24 and 72 h) for 90Y-Fe3O4-DPD 
MNPs by cervical dislocation. The results of the uptake into 
organs were expressed as a percentage of the injected activity 
per gram (% ID/g) and per ml of blood, when compared with 
appropriate standards for the injected dose (ID). 
The Ethical Committee of the Vinča Institute of Nuclear 
Sciences, University of Belgrade, approved this study, and 
permission was obtained according to the Law for Animal 
Welfare from the Ministry of Agriculture and Environmental 
Protection, Republic of Serbia (permission number
323-07-04725/2018-05).
3 Results and discussion
3.1 Measurements in alternating and non-alternating MF
For medical applications of magnetic hyperthermia, 
physiological limitations should be well-thought-out. High- 
frequency MF can cause local heating in the part of the tissue 
where no magnetic particles were found, owing to the eddy 
currents. Besides clinical limitations, technical limitations 
should be also kept in mind, as most of studies on biological 
specimens take place in a narrow range of frequencies. The 
applied frequencies, along with the amplitude of the AC field 
are generally grounded on literature data. In the absence of a 
better criterion, most of the authors cite papers by Atkinson22 
and Brezovich.23
The temperature increase of Fe3O4-DPD MNPs (2 mg/ml) as 
a function of the time was evaluated under different 
frequencies 252–577 kHz and a magnetic field strength of 30 
mT (Fig.2). From the temperature curve, it was observed that 
Fe3O4-DPD MNPs shows heating effect even at 252 kHz.
Besides the applied frequency and field strength, 
physicochemical characteristics of the sample such as particle 
size and shape as well as the concentration of the sample 
strongly affect the behavior of MNPs both in alternating and 
Figure 2 - Heating capacity of Fe3O4-DPD MNPs at 30mT and different field 
frequencies
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Table1 - SPA values of Fe3O4-DPD MNPs at different concentrations                           
(397 kHz, 30 mT)
Concentration (mg/ml) SPA 
(W/g)
0.25 0
0.5 0
1 0
2 81
5 91
8 92
non-alternating MF. Generally, higher concentrations of MNPs 
widen the application of different electric and magnetic 
fields.24 By dilution of the Fe3O4-DPD ferrofluid SPA values 
decrease and at concentrations below 2 mg/ml hyperthermia 
effect could not be observed (Table 1).
The behavior of Fe3O4-DPD MNPs in non-alternating MF (30 
mT) for different concentrations is depicted in Fig. 3.The detail 
explanation of the effect has been described in previous 
paper18, hence only the basic theoretical considerations have 
been given here. Regardless of the concentration used, at the 
beginning of the measuring, when the MF is switched-off, the 
sample has shown the initial transparency. At the point, when the 
MF is switched-on, a swift decrease of intensity of transmitted light 
was observed. The width and depth of the valley depend on the 
used MF and on the type of ferrofluid, as observed previously18. 
After some time rapid increase in the intensity of transmitted light 
occurs. At a certain point, the saturation effect has been noticed. 
This rise of the intensity is according to the model25 and is due to 
the orientation of the magnetic domains of nanoparticles caused by 
MF. 
 Non-alternating MF forces magnetic particles along the field 
lines, likewise magnetic needles. Magnetic domains ordered in such 
a manner are attracted forming magnetic chains. Further on, the 
chains can be organized to form a quasi-lattice of magnetic threads. 
This aggregation process depends on the field strength and the time 
interval of the exposure. During the time, the sizes of scatterers 
increase due to the formation of doublets, triplets or very small 
chains25-31. At a certain time point, a number of scatterers sizes 
satisfy the resonances in the scattering anisotropy and extinction 
efficiency factors. At the minimum transparency, the number of 
caterers satisfying the resonance becomes maximum. When MF 
was switched off, the sample becomes more transparent and the 
intensity of transmitted light increases rapidly. This is due to 
theadditional attachment of free magnetic nanoparticles in the 
solution and their embedding into magnetic chains.Precipitation of 
the sample during the time in the non-alternating MF has been 
depicted in Fig. 4.
Monitoring the effect of non-alternating MF by measuring 
the transparency of the Fe3O4-DPD ferrofluid, was not possible 
at concentrations ≥ 5 mg/ml due to the high density of the 
sample. At the highest tested concentration (2 mg/ml) the 
ratio between well depth and height of transparency increase 
is the largest (Fig.3). Also, the width of the well is the smallest 
for the highest concentrations. By dilution of the sample (1 
mg/ml and 0.5 mg/ml) the ratio between well depth and 
height of transparency increase has been decreased. At the 
same time the width of the well increases. At the lowest 
concentrations (0.25 mg/ml), the increase of transparency is 
very small reaching only the initial value (when the MF was 
switched-off). Below 2 mg/ml the heating capacity of the 
sample has not been observed and also the drastic change of 
curve profiles in non-alternating MF has been noticed. 
The addition of sodium chloride to the ferrofluid sample 
drastically affects their behavior in both alternating and non-
alternating MF. Strong aggregation of coated nanoparticles, 
Figure 3 -Time dependence of transmitted diode laser light (λ=655 nm) for 
different concentrations of the sample at magnetic field strength of 30 mT.
Figure 5 -The dependence of SPA values and hydrodynamic diameter on ionic 
strength at 30 mT and 397 kHz.
Figure 4 - Fe3O4-DPD MNPs sample: a) In the absence of non-alternating MF; b)-
g) In the presence of non-alternating MF (30 mT); h) At the saturation point  
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characterized by a steep increase in hydrodynamic diameter, 
occurs when the ionic strength reaches a value of 0.4 
mol/dm3(Fig.5). The process of aggregation is getting stronger 
with the further increase of NaCl concentration. Bellow the 0.4 
mol/dm3 the change of hydrodynamic diameter is less intense. 
The aggregation process is associated with simultaneous 
changes in SPA values. At 0.4 mol/dm3 drastic decline have 
been observed. In the concentration range of 0.5-1.0 mol/dm3 
NaCl, the decrease of 45 %, with respect to SPA values 
measured for ionic strength 0-0.3 mol/dm3 occurred.
At higher ionic strengths (higher NaCl concentrations), the 
Fe3O4-DPD MNPs became less stable compared to the lower 
ionic strengths. This indicates that the thickness of the DPD 
coating on the Fe3O4 surface is not high enough to stabilize the 
particles. In Fig.5, it has been shown that the hydrodynamic 
diameter increases at high salt concentration, which results in 
agglomeration and precipitation. At a low salt concentration, 
the repulsive forces are dominant over the attractive forces 
and the particle size was not changed significantly. By the 
increase of the ionic strength, the decrease in the electron-
alternating forces occur, rising the receptiveness of the 
dispersed particles to form aggregates.11,32
In non-alternating MF, regardless of NaCl concentration, 
initial transparency of the sample (when a magnetic field is 
switched-off) decreases with time (Fig.6). The increase of NaCl 
concentration up to 0.5 mol/dm3 leads to the blurring of 
ferrofluid, i.e. the initial transparency is higher for lower 
concentrations of NaCl. At concentrations higher than 0.5 
mol/dm3 the adverse effect was observed since the 
precipitation of magnetic particles is larger as showed with DLS 
measurements (Fig.5).
At the time when MF was switched-on the abrupt 
depression of transparency of all samples was observed. The 
effect of MF on magnetic particles in solution, i.e. the increase 
of transparency is the largest for the ferrofluid sample without 
NaCl. Addition of small amounts of NaCl (0.05-0.3 mol/dm3) 
drastically changes transparency values. It is obvious that even 
small concentrations of electrolyte interfere with the magnetic 
field effect. However, up to 0.3 mol/dm3, all curves have a 
similar convex shape. For concentrations higher than 0.3 
mol/dm3 the shape of the curves is different. At a 
concentration of 0.4 mol/dm3, the increase of transparency 
showed the nearly linear path. For the concentration range of 
0.6-1.0 mol/dm3, the curves are concave. The observed effect 
of MF on magnetic particles is drastically weaker in the 
concentration range of 0.4-1.0 Mol/dm3, compared to lower 
concentrations of NaCl. The higher concentrations of NaCl lead 
to increased precipitation of magnetic particles, which makes 
them difficult to orientate with respect to MF and to create 
magnetic chains under field effect, as explained 
previously.18,25–31
The larger aggregation of MNPs due to the presence of 
electrolyte leads to the increase of magnetic interactions 
between nanoparticles and magnetic response with respect to 
the external field is diminished. As a consequence, change in 
the transparency profile of the sample and decrease of 
hyperthermia efficiency was observed. Furthermore, the 
demagnetizing field induced within the aggregates due to their 
magnetization, decreases the local magnetic field, leading to a 
reduction of transparency and SPA.11
In the range of the lower ionic strengths (0.05-0.3 mol/dm3 
NaCl) which are approximate to the physiological conditions, 
negligible changes in hydrodynamic diameters and SPA values 
of MNPs have been observed. In accordance, the 
measurements in the non-alternating MF for the same 
concentration range have shown the curve profiles which do 
not differ from one another significantly up to a concentration 
of 0.4 mol/dm3 NaCl.
3.2 Radiolabeling of Fe3O4-DPD MNPs
The radiotracer technique is a relevant approach for 
studying uptake, distribution and biodegradation of newly 
designed nanoparticles. BPs bind very strongly to the surface 
of magnetic nanoparticles allowing further labeling with 
diagnostic and therapeutic radionuclides.19,33 In our previous 
work7, design, synthesis, characterization and radiolabeling of 
a Fe3O4-DPD MNPs with the positron emitter 68Ga were 
described showing their high potential as an imaging agent for 
PET/MRI.
Radiolabeling of Fe3O4-DPD MNPs was possible with both 
examined radionuclides 99mTc and 90Y, using the chelator-free 
radiolabeling method. These radionuclides make stable 
complexes with a variety of groups that are present on the 
nanoparticle surface.34 Radiolabeling of Fe3O4-DPD MNPs was 
performed at high yields (>98 % for 99mTc and >93 % for 90Y), as 
in the case of other BPs coated nanoparticles.19,33 This was 
expected,considering that DPD, as a tetradentate ligand with 
two phosphonates and two carboxylates, is a suitable ligand 
for direct labeling with radiometals.15
Table 2: In vitro stability of 99mTc-Fe3O4-DPD MNPs during 24 h at 37 oC in different 
incubation medium: saline, human serum and 0.01 mol/dm3 DTPA.
Radiochemical purity, RCP (%)
Incubation time
Incubation 
medium
0.5 h 1 h 2 h 6 h 24 h
Saline 98.6 98.1 98.0 96.1 92.9
Human serum 93.7 92.4 91.3 88.9 84.2
DTPA 98.5 98.0 97.7 95.8 91.5
Figure 6 -Time dependence of transmitted diode laser light (λ=655 nm) for 
different ionic strengths at magnetic field strength of 30 mT
Page 5 of 9 New J urnal of Che istry
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
N
ew
Jo
ur
na
lo
fC
he
m
is
tr
y
A
cc
ep
te
d
M
an
us
cr
ip
t
Pu
bl
ish
ed
 o
n 
14
 M
ar
ch
 2
01
9.
 D
ow
nl
oa
de
d 
by
 U
ni
ve
rs
ity
 o
f T
ex
as
 at
 D
al
la
s o
n 
3/
15
/2
01
9 
8:
43
:1
6 
A
M
. 
View Article Online
DOI: 10.1039/C8NJ06478D
ARTICLE Journal Name
6 | J. Name., 2012, 00, 1-3 This journal is © The Royal Society of Chemistry 20xx
Please do not adjust margins
Please do not adjust margins
Table 3: In vitro stability of 90Y-Fe3O4-DPD MNPs during 72 h at 37 oC in different 
incubation medium: saline, human serum and 0.01 mol/dm3 DTPA.
Radiochemical purity, RCP (%)
Incubation time
Incubation 
medium
0.5 h 1 h 24 h 48 h 72 h
Saline 93.1 92.8 91.5 89.3 87.6
Human serum 91.4 90.7 87.6 84.1 79.4
DTPA 93.3 93.1 92.5 91.5 91.3
3.3 In vitro stability of radiolabeled Fe3O4-DPD MNPs
With the aim of assessing the in vitro stability of 
radiolabeled Fe3O4-DPD MNPs in biological media, they were 
incubated in saline, human serum and DTPA solution at 37 oC 
during a certain period of time. The proportion of the total 
radioactivity in the sample presented in the form of the 
desired radioactive nanoprobe (99mTc-Fe3O4-DPD MNPs) is 
expressed as radiochemical purity, RCP (Tables 2 and 3). The 
RCP values of 99mTc- Fe3O4-DPD MNPs determined after 24 h 
incubation in saline, human serum and DTPA solution (92.9 %, 
84.2 % and 91.5 %, respectively), showed that 99mTc-Fe3O4-DPD 
MNPs exhibited excellent in vitro stability, regardless the 
incubation conditions. 
A negligible amount of 90Y was lost from the radiolabeled 
MNPs after 72 h incubation in all tested media, showing RCP 
87.6 %, 79.4 % and 91.3 % for saline, human serum and DTPA, 
respectively. This indicated that 90Y-Fe3O4-DPD MNPs 
remained stable for at least 3 days under physiological 
conditions.
Similar results were obtained for 68Ga-Fe3O4-DPD MNPs 
after 2 h incubation in PBS and human serum, showing RCP 
values > 80 %.7
3.4 Biodistribution Studies
Biodistribution and clearance of nanoparticles depend on 
their chemical and biochemical properties such as size, surface 
functionality and charge.35,36 In general, it is well-established 
that nanoparticles are taken up by the RES system following 
i.v. administration, leading to the clearance of nanoparticles 
from systemic circulation.37 Biodistribution of Fe3O4-DPD 
MNPs was studying over 24 h and 72 h after i.v. injection of 
99mTc-Fe3O4-DPD and 90Y-Fe3O4-DPD MNPs respectively, by 
measuring the radioactivity of the radiolabeled compounds in 
various tissues.37-39 It was possible to compare the 
biodistribution profiles obtained by using two radioisotopes in 
order to confirm the efficiency and in vivo stability of the 
radiolabeled MNPs. 90Y with a half-life of 2.8 days was used for 
the biodistribution analysis over 3 days, while 99mTc is not 
suitable for long time biodistribution evaluation due to 6 h 
half-life. Tissue distribution expressed as the percentage of 
injected dose per gram tissue is presented in Fig.7. High 
accumulation of MNPs was mainly observed in the liver 1 h 
after i.v. administration (16.03 % ID/g for 99mTc-Fe3O4-DPD and 
11.28 % ID/g for 90Y-Fe3O4-DPD MNPs) as well as the long-term 
retention in the same organ. Low accumulation of both 
radiolabeled nanoprobes in lungs was observed. These results 
demonstrate that hydrophilic DPD coating prevents Fe3O4 
MNPs aggregation under in vivo conditions, as is the case with 
naked MNPs.40 Owing to the fact that trivalent radiometals 
such as yttrium are predominantly taken from circulation by 
bones,41 low release of 90Y from radiolabeled MNPs was 
proved by insignificant bone uptake indicating in vivo stability 
of 90Y-Fe3O4-DPD MNPs. Also, due to the in vivo stability of 
99mTc-Fe3O4-DPD MNPs, the insignificant radioactivity in the 
stomach at all time-points was observed. 
Conclusions
The interaction of Fe3O4-DPD MNPs with alternating 
external magnetic field is of special interest due to their 
possible application in hyperthermia treatment. The results 
presented imply that the DPD-coated MNPs could maintain 
their heating capacity in the range of 252-577 kHz and thus 
have potential in biomedical applications. 
Further, for the better understanding of hyperthermia, the 
interaction of Fe3O4-DPD MNPs with a non-alternating 
magnetic field was examined. An increase of ionic strength of 
samples leads to the aggregation of MNPs. This process has 
been monitored by measuring of SPA values, hydrodynamic 
Figure 7 -Biodistribution of a) 99mTc-Fe3O4-DPD and b) 90Y-Fe3O4-DPD MNPs after intravenous administration in normal Wistar rats (% ID/g)
Page 6 of 9New J urnal of Che istry
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
N
ew
Jo
ur
na
lo
fC
he
m
is
tr
y
A
cc
ep
te
d
M
an
us
cr
ip
t
Pu
bl
ish
ed
 o
n 
14
 M
ar
ch
 2
01
9.
 D
ow
nl
oa
de
d 
by
 U
ni
ve
rs
ity
 o
f T
ex
as
 at
 D
al
la
s o
n 
3/
15
/2
01
9 
8:
43
:1
6 
A
M
. 
View Article Online
DOI: 10.1039/C8NJ06478D
Journal Name ARTICLE
This journal is © The Royal Society of Chemistry 20xx J. Name., 2013, 00, 1-3 | 7
Please do not adjust margins
Please do not adjust margins
diameter and transparency in the non-alternating field. Within 
the range of 0.05-0.3 mol/dm3 NaCl, similar to the 
physiological conditions, minor changes in hydrodynamic 
diameters and SPA values have been observed. In an 
agreement, the measurements in the non-alternating MF for 
the same concentration range have shown a similar trend up 
to a concentration of 0.4 mol/dm3 NaCl. Transparency 
measurement of Fe3O4-DPD MNPs in non-alternating MF 
clarified the mechanism of particle aggregation before 
switching on MF, when the field is applied and after the 
switching off MF. These measurements gave us insight into the 
orientation of magnetic domains and aggregate formation in 
the absence and the presence of electrolyte which allows a 
more comprehensive understanding of hyperthermia.
Coated MNPs were radiolabeled for two purposes: to use 
the radiotracer to obtain an accurate biodistribution profile of 
the Fe3O4-DPD MNPs and to investigate the preparation of the 
potential therapeutic and diagnostic agents. 90Y-Fe3O4-DPD 
and 99mTc-Fe3O4-DPD MNPs were obtained in high 
radiolabeling yield and exhibited high in vitro stability in saline, 
human serum and DTPA solution. The results of biodistribution 
showed high uptake in the liver and spleen after i.v. 
administration as well as in vivo stability and long retention in 
these organs. Radiolabeled Fe3O4-DPD MNPs with different 
metallic radionuclides such as 99mTc and 90Y, seem to hold great 
potential as theranostic agents with improved diagnostic and 
therapy abilities.
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